ESCALON MEDICAL CORP (ticker: ESMC) is an OTC-listed clinical biotech company. DredgeCap's structured extraction of ESMC's SEC filings surfaces 14 active risk signals, including 11 late-filing signals, 2 auditor-change signals, and 1 delisting/deregistration signal. ESMC reported $9.48M in revenue and -$142K for the period ending 2025-03-31, with operating cash flow of -$432K. Cash and equivalents stood at $337K (down 35.2% year-over-year). Total assets of $4.69M exceed total liabilities of $3.21M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ESMC Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for ESCALON MEDICAL CORP (ESMC) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.